FeraMAX® Pd 75
Natural health product licensed in Canada
- Licence holder
- BioSyent Pharma Inc.
- NPN or DIN-HM
- 80132196
- Status
- Active licence
- Licence date
- 4 July 2024
- Revision date
- 17 July 2024
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B12 Source : Cyanocobalamine | 1,000 Microgrammes | Not calculated |
Non-medicinal ingredients
Phosphate dicalcique, Amidon de riz, Laque d'aluminium rouge D&C no. 27, Hypromellose, Cire de Carnauba, Laque d'aluminium jaune FD&C No. 5, Laque d'aluminium bleu FD&C n° 1, Phosphate de dicalcium dihydraté, NA, Croscarmellose de sodium, Stéarate de magnésium, Isomalt, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps pregnant women meet (the) (Health Canada's) recommended intake for iron, when taken in conjunction with a healthy diet. Helps to prevent iron deficiency. Helps to reduce the risk of neural tube defects when taken daily at least three months prior to becoming pregnant and during early pregnancy. Helps to support normal early fetal development (brain and spinal cord). Helps prevent development of iron deficiency prior to pregnancy. Helps support early fetal development of the brain and spinal cord and reduce the risk of neural tube defects when taken daily prior to and during pregnancy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80132196
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging